Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cutibacterium Acnes: later-stage trial registry
1 of 3 indexed Cutibacterium Acnes trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Cutibacterium Acnes: 3 US clinical trials tracked, 1 recruiting.
Cutibacterium Acnes is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is St. Louis University, running 2 of these trials.
Enrollment posture brief
Registry condition cutibacterium-acnes
OPEN 1 | RECR 33% | LATE 1 | EARLY 0 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Cutibacterium Acnes lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cutibacterium Acnes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cutibacterium Acnes is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Reduction of Bacterial Seeding in Total Shoulder Arthroplasty
St. Louis University
NCT07406893
Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?
University of Utah
NCT06513182
SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty
St. Louis University
NCT05919888
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cutibacterium Acnes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cutibacterium Acnes trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cutibacterium Acnes page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Cutibacterium Acnes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- St. Louis University sponsors the most Cutibacterium Acnes trials on record, review their full trial history before evaluating a specific study. See St. Louis University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cutibacterium Acnes condition card totals 3 registered trials; most-linked intervention SURGX Wound Gel; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.